Ketamine and Anxiety: Can Infusion Therapy Help Generalized Anxiety Disorder?

Generalized anxiety disorder (GAD) is more than everyday worry. It is a persistent, often debilitating condition that affects approximately 6.8 million American adults — a chronic state of apprehension that resists the usual reassurance of "just relax." For patients who have tried standard medications without adequate relief, ketamine therapy is emerging as a promising alternative that targets anxiety at the neural circuit level.

The Neurology of Anxiety: An Overactive Alarm System

To understand why ketamine may help anxiety, it helps to understand what is happening in the anxious brain. Neuroimaging research has identified several consistent patterns in patients with GAD:

• Overactive amygdala: The amygdala, the brain's threat detection center, shows heightened activity in GAD patients. It fires alarm signals in response to stimuli that the rational brain knows are not dangerous, but the amygdala does not distinguish between genuine threats and perceived ones. This chronic hyperactivation drives the persistent sense of dread that defines generalized anxiety.
• Weakened prefrontal regulation: The prefrontal cortex normally modulates amygdala activity, providing the "it's okay, you're safe" signal that dampens fear responses. In GAD, the functional connectivity between the prefrontal cortex and the amygdala is impaired, leaving the alarm system running without an adequate brake.
• Default mode network dysfunction: The default mode network (DMN) — the brain system active during self-referential thinking — shows altered patterns in anxiety. Instead of facilitating normal reflective thought, an overactive DMN drives rumination and catastrophic thinking: the repetitive "what if" loops that consume so much mental energy in GAD.

These are not character traits. They are measurable neurological patterns that explain why anxiety feels so involuntary and why simply telling yourself to stop worrying rarely works. The hardware is misfiring, and effective treatment needs to address the hardware.

The Limitations of Current Anxiety Treatments

Benzodiazepines: Effective but Problematic

Benzodiazepines (alprazolam, lorazepam, clonazepam) remain among the most commonly prescribed medications for acute anxiety. They work quickly and effectively by enhancing GABA activity, the brain's primary inhibitory neurotransmitter. The problem is what comes next: physical dependency can develop within weeks, tolerance builds requiring escalating doses, and cognitive side effects (memory impairment, slowed processing, sedation) limit function. Discontinuation after prolonged use can produce withdrawal symptoms that are worse than the original anxiety.

For these reasons, benzodiazepines are increasingly recognized as a short-term solution that creates long-term problems. Most clinical guidelines now recommend against their use as a first-line, ongoing treatment for GAD.

SSRIs for Anxiety: Partial Solutions

SSRIs (sertraline, escitalopram, paroxetine) are the current first-line pharmacological treatment for GAD. They avoid the dependency issues of benzodiazepines, but their limitations are significant: they take 4–8 weeks to reach full therapeutic effect, response rates for anxiety are approximately 40–60%, and many patients experience side effects (sexual dysfunction, weight gain, emotional blunting) that compromise quality of life. For the substantial percentage of patients who do not respond adequately, options narrow quickly.

How Ketamine Targets Anxiety Circuits

Ketamine's mechanism of action is particularly well-suited to the neurological profile of anxiety. As an NMDA receptor antagonist, ketamine modulates the glutamate system — the brain's primary excitatory network — in ways that directly address the circuit dysfunction underlying GAD.

For anxiety patients specifically, this means:

• Strengthened prefrontal regulation: Enhanced synaptic connectivity in the prefrontal cortex restores its ability to modulate amygdala hyperactivity — essentially rebuilding the brake that anxiety has degraded
• Calmed overactive circuits: Ketamine's effects on glutamate signaling help normalize the excessive excitatory activity that drives chronic anxiety states
• DMN modulation: Research suggests ketamine temporarily disrupts default mode network activity, which may interrupt the ruminative thought loops that characterize GAD and allow the brain to reset into less anxious patterns
• Rapid onset: Unlike SSRIs, which take weeks, ketamine's anxiolytic effects can emerge within hours to days, providing relief for patients who have been suffering for extended periods

Clinical Evidence: What Research Shows

While the evidence base for ketamine in anxiety disorders is newer and smaller than the depression data, the results are encouraging:

• Glue et al. (2017): A randomized controlled trial published in Neuropsychopharmacology demonstrated that a single subcutaneous ketamine dose produced significant reductions in anxiety symptoms compared to placebo in patients with treatment-refractory GAD and social anxiety disorder. Improvement was evident within one hour and persisted for up to one week.
• Taylor et al. (2018): Research examining ketamine's effects on anxiety symptoms in patients with comorbid depression and anxiety found significant anxiolytic effects, with anxiety symptom reduction paralleling or in some cases exceeding antidepressant effects.
• Comorbidity data: Because anxiety and depression frequently co-occur, many of the large ketamine depression trials have also measured anxiety outcomes. These studies consistently show that ketamine produces meaningful reductions in anxiety symptoms alongside its antidepressant effects, with response rates for comorbid anxiety of approximately 50–70%.

The evidence increasingly suggests that ketamine's anxiolytic effects are not merely a byproduct of its antidepressant action — they reflect a distinct mechanism that directly addresses anxiety-related neural circuits.

What Anxiety Patients Can Expect During Infusions

One understandable concern for anxiety patients considering ketamine therapy is the infusion experience itself. People with anxiety disorders are often highly sensitive to altered states, and the prospect of a dissociative medication can feel counterintuitive.

Here is what patients typically report:

• Onset (5–10 minutes): A gradual sensation of relaxation, sometimes described as feeling "lighter" or "floaty." The perceptual changes develop slowly, not abruptly.
• Peak experience (15–30 minutes): Mild dissociation — a sense of distance from usual thought patterns. Many anxiety patients describe this as the first time in years their mind has been genuinely quiet. The relentless worry loop may temporarily pause.
• Resolution (final 10–15 minutes): Effects gradually recede. Patients typically feel calm and somewhat reflective rather than anxious.
• Post-infusion: Most patients feel tired but peaceful. Some describe a sense of emotional clarity that persists for days to weeks.

At LUMUS, the clinical team is experienced in supporting anxiety patients through the infusion process. The environment is carefully controlled for comfort, and patients can communicate with staff at any point during the session.

Treatment Protocol Considerations for Anxiety

The standard protocol for anxiety mirrors the depression protocol: six IV infusions over two to three weeks, followed by individualized maintenance infusions. However, there are some specific considerations for anxiety patients:

• Dosing: Some anxiety patients respond well to slightly lower doses than the standard 0.5 mg/kg depression protocol. Dr. Garcia adjusts dosing based on individual response and tolerability.
• Integration with therapy: The enhanced neural plasticity following ketamine infusions creates a window during which cognitive behavioral therapy (CBT) may be particularly effective. We coordinate with patients' therapists to optimize timing.
• Maintenance planning: Anxiety symptoms tend to be chronic, and maintenance infusions are typically an important part of the long-term plan.

When Ketamine May Not Be Appropriate for Anxiety

Ketamine therapy is not appropriate for every anxiety patient. Conditions that may preclude treatment or require careful evaluation include:

• Active psychotic disorders: Ketamine's dissociative properties could exacerbate psychotic symptoms
• Severe dissociative disorders: Patients with pre-existing dissociative conditions require careful assessment before ketamine therapy
• Uncontrolled hypertension: Ketamine can temporarily elevate blood pressure and heart rate
• Active substance abuse: Particularly with dissociative substances or alcohol, which interact with similar neural pathways
• Panic disorder as primary diagnosis: While ketamine may help some panic disorder patients, the evidence is limited, and the acute dissociative experience may not be appropriate for all patients with panic symptoms

Dr. Garcia's Evaluation Approach: Precision Psychiatry

Anxiety disorders are frequently misdiagnosed, undertreated, or treated with medications that address symptoms without reaching the underlying neural dysfunction. Dr. Michael Garcia's evaluation process at LUMUS is designed to move beyond surface-level diagnosis to understand the specific pattern of anxiety each patient experiences.

His dual board certification in psychiatry and addiction medicine is particularly relevant for anxiety patients, as many have complex medication histories (including benzodiazepine use) and comorbid conditions that require careful clinical navigation. The evaluation includes a comprehensive assessment of current medications, prior treatment responses, substance use history, and an honest discussion about whether ketamine is the right tool for each individual's specific situation.

Anxiety does not have to be a permanent state. If standard treatments have not provided adequate relief, ketamine therapy may offer a neurologically grounded approach to calming the circuits that keep your mind locked in overdrive. The science is promising, the treatment is well-tolerated, and the first step is a conversation about whether it is right for you.